CORD-19:2008f024274c53b0de1276f4047a6a641813fd98 / 645484-645678
Annnotations
{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/2008f024274c53b0de1276f4047a6a641813fd98","sourcedb":"CORD-19","sourceid":"2008f024274c53b0de1276f4047a6a641813fd98","text":"The studies were 2-week, multicenter, double-blind, placebo-controlled trials that began with a 1-week, open-label lead-in period in which patients received either loratadine 10 mg qd (Study No.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"T90329","span":{"begin":0,"end":194},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T90329","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T136","span":{"begin":0,"end":194},"obj":"Sentence"}],"attributes":[{"subj":"T136","pred":"source","obj":"CORD-19_Custom_license_subset"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#eca193","default":true},{"id":"CORD-19_Custom_license_subset","color":"#939eec"}]}]}}